The physiological importance of erythrocyte acetylcholinesterase and its contribution to the development of intoxication with AChE inhibitors
Public support
Provider
Ministry of Health
Programme
—
Call for proposals
—
Main participants
Ministerstvo obrany / Univerzita obrany - Vojenská lékařská fakulta
Contest type
—
Contract ID
—
Alternative language
Project name in Czech
Fyziologický význam erytrocytární acetylcholinesterázy a její podíl na rozvoji intoxikace inhibitory AChE
Annotation in Czech
Vytvoření zvířecího modelu s erytrocyty bez aktivity acetylcholinesterázy za účelem sledování vlivu absence erytrocytární AChe na základní fyziologické funkce a průběh otravy inhibitory cholinesteráz.
Scientific branches
R&D category
—
CEP classification - main branch
FP - Other medical fields
CEP - secondary branch
—
CEP - another secondary branch
—
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
30106 - Anatomy and morphology (plant science to be 1.6)<br>30107 - Medicinal chemistry<br>30108 - Toxicology<br>30109 - Pathology<br>30221 - Critical care medicine and Emergency medicine<br>30223 - Anaesthesiology<br>30224 - Radiology, nuclear medicine and medical imaging<br>30225 - Allergy<br>30226 - Rheumatology<br>30227 - Geriatrics and gerontology<br>30229 - Integrative and complementary medicine (alternative practice systems)<br>30230 - Other clinical medicine subjects<br>30307 - Nursing<br>30308 - Nutrition, Dietetics<br>30309 - Tropical medicine<br>30310 - Parasitology<br>30311 - Medical ethics<br>30312 - Substance abuse<br>30501 - Forensic science<br>30502 - Other medical science
Solution timeline
Realization period - beginning
Jan 1, 1997
Realization period - end
Jan 1, 1998
Project status
K - Ending multi-year project
Latest support payment
—
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP/1998/MZ0/MZ08IZ/V/3:3
Data delivery date
—
Finance
Total approved costs
217 thou. CZK
Public financial support
217 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
0 thou. CZK